3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma RELH

Rhelion Life Sciences Corp.

RELH CSE Biotech & Pharma

Stock factsheet

TickerRELH
ExchangeCSE
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 9 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Rhelion Life Sciences Corp’s business revolves around the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

Company description as published by the issuer via Canadian Securities Exchange.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Rhelion Life Sciences Corp.RELH CSE9 Mio. USD
Hemostemix Inc. HEMTSXV 9 Mio. USD
AI-ML Innovations Inc. AIMLCSE 9 Mio. USD
HYTN Innovations Inc HYTNCSE 9 Mio. USD
Seegnal Inc. SEGNTSXV 9 Mio. USD
Medicure Inc. MPHTSXV 10 Mio. USD
Captiva Verde Wellness Corp. PWRCSE 8 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.